# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA615364 | B | Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates | 2 | single protein format | Scientific Literature | |||
2. | ALA615365 | F | 90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates | 7 | assay format | Scientific Literature | |||
3. | ALA857899 | F | Minimum inhibitory concentration of compound against Streptococcus pyogenus septicemia in the mouse | Streptococcus pyogenes | 1 | organism-based format | Scientific Literature | ||
4. | ALA676913 | F | In vitro antibacterial activity of compound against Escherichia coli SKF 12140 | Escherichia coli | 22 | organism-based format | Scientific Literature | ||
5. | ALA857202 | F | In vitro antibacterial activity of compound against Haemophilus influenzae ATCC 19418 | Haemophilus influenzae | 22 | organism-based format | Scientific Literature | ||
6. | ALA703016 | F | In vitro antibacterial activity of compound against Klebsiella pneumoniae ISM | Klebsiella pneumoniae | 22 | organism-based format | Scientific Literature | ||
7. | ALA715915 | F | In vitro antibacterial activity of compound against Mycobacterium tuberculosis H37Rv ATCC 9660; ND means not determined | Mycobacterium tuberculosis | 4 | organism-based format | Scientific Literature | ||
8. | ALA749109 | F | 50% inhibition of the 20 Mycobacterium (MAC) avium complex clinical isolates | Mycobacterium avium | 11 | organism-based format | Scientific Literature | ||
9. | ALA750222 | F | In vitro antibacterial activity of compound against Neisseria gonorrhoeae ISM 68/126 | Neisseria gonorrhoeae | 22 | organism-based format | Scientific Literature | ||
10. | ALA771779 | F | In vitro antibacterial activity of compound against Proteus vulgaris X19H ATCC 881 | Proteus vulgaris | 22 | organism-based format | Scientific Literature | ||
11. | ALA764310 | F | In vitro antibacterial activity of compound against Pseudomonas aeruginosa ATCC 10145 | Pseudomonas aeruginosa | 22 | organism-based format | Scientific Literature | ||
12. | ALA807560 | F | In vitro antibacterial activity of compound against Staphylococcus aureus Tour L 165 | Staphylococcus aureus | 22 | organism-based format | Scientific Literature | ||
13. | ALA804734 | F | Inhibitory concentration of compound against Streptococcus pyogenus septicemia in the mouse, administarted in OS route | Streptococcus pyogenes | 5 | organism-based format | Scientific Literature | ||
14. | ALA804735 | F | Inhibitory concentration of compound against Streptococcus pyogenus septicemia in the mouse, administarted in subcutaneous route | Streptococcus pyogenes | 4 | organism-based format | Scientific Literature | ||
15. | ALA806441 | F | In vitro antibacterial activity of compound against Streptococcus pyogenes C 203 SKF 13400 | Streptococcus pyogenes | 22 | organism-based format | Scientific Literature | ||
16. | ALA804398 | F | In vitro antibacterial activity of compound against Staphylococcus epidermidis ATCC 12228 | Staphylococcus epidermidis | 22 | organism-based format | Scientific Literature | ||
17. | ALA811102 | F | In vitro antibacterial activity of compound against Streptococcus pneumoniae UC 41 | Streptococcus pneumoniae | 22 | organism-based format | Scientific Literature | ||
18. | ALA812165 | F | In vitro antibacterial activity of compound against Streptococcus faecalis ATCC 7080. | Enterococcus faecalis | 22 | organism-based format | Scientific Literature |